US › Healthcare

OKYO Pharma Ltd ADR (OKYO)

US · Healthcare · Biotechnology

$1.64-1.80%
Last close · 2026-08-04

Key statistics

Market cap
$88.2M
Forward P/E
0.0
P/B
7.15
Book value
$0.23
EPS (TTM)
$-0.24
52-week high
$3.35
52-week low
$1.34
50-day MA
$1.59
200-day MA
$1.86
Beta
0.02

Analyst view

Analysts rate OKYO Pharma Ltd ADR a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $8.33.

Shareholding

Insiders
30.99%
Institutions
20.81%

Largest institutional holders

FundStake
Woodline Partners LP6.96%
MAVEN SECURITIES Ltd2.24%
Stonepine Capital Management Llc1.62%
Balyasny Asset Management LLC1.11%
UBS Group AG0.11%
XTX Topco Ltd0.07%
HPM Partners LLC0.02%
Geode Capital Management, LLC0.02%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for OKYO Pharma Ltd ADR — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.